Oral Delivery of Tumor-Targeting Salmonella to Treat Cancer in Mice

  • Dongping Wei
  • Lijun JiaEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1409)


Tumor-targeting bacteria have been developed as novel anticancer agents recently. To achieve their therapeutic effects, bacteria have conventionally been injected intravenously or intraperitoneally into animals or humans. Here, we describe the oral delivery of tumor-targeting Salmonella for cancer therapy in a mouse tumor model. We detail the experimental procedures for establishing a mouse tumor model, preparing bacterial culture, mouse gavage, and detection of the tumor-targeting capability of bacteria administered orally. We also discuss technical notes and provide practical advice that will help the users of this oral delivery model.

Key words

Oral delivery Tumor-targeting bacteria Salmonella Solid tumor Cancer therapy 



We thank Lihui Li and Xiaoxin Zhang for their technical assistance. This study was supported by grants from the Chinese National Natural Science Foundation (30500637 to Lijun Jia; 81472793 to Dongping Wei) and Key Project of the Shanghai Municipal Health Bureau (2010012 to Lijun Jia).


  1. 1.
    Yazawa K, Fujimor IM, Amano J, Kano Y, Taniguchi S (2000) Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther 7:269–274CrossRefPubMedGoogle Scholar
  2. 2.
    Lee CH, Wu CL, Shiau AL (2004) Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models. J Gene Med 6:1382–1393CrossRefPubMedGoogle Scholar
  3. 3.
    Zheng LM, Luo X, Feng M et al (2000) Tumor amplified protein expression therapy: Salmonella as a tumor-selective protein delivery vector. Oncol Res 12:127–135CrossRefPubMedGoogle Scholar
  4. 4.
    King I, Bermudes D, Lin S et al (2002) Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent. Hum Gene Ther 13:1225–1233CrossRefPubMedGoogle Scholar
  5. 5.
    Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B (2001) Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci USA 98:15155–15160PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Dang LH, Bettegowda C, Agrawal N et al (2004) Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agents. Cancer Biol Ther 3:326–337CrossRefPubMedGoogle Scholar
  7. 7.
    Lee CH, Wu CL, Tai YS, Shiau AL (2005) Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy. Mol Ther 11:707–716CrossRefPubMedGoogle Scholar
  8. 8.
    Chen J, Wei D, Zhuang H, Qiao Y, Tang B, Zhang X, Wei J, Fang S, Chen G, Du P, Huang X, Jiang W, Hu Q, Hua ZC (2011) Proteomic screening of anaerobically regulated promoters from Salmonella and its antitumor applications. Mol Cell Proteomics 10:M111.009399PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Bettegowda C, Dang LH, Abrams R et al (2003) Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria. Proc Natl Acad Sci USA 100:15083–15088PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Jia LJ, Xu HM, Ma DY et al (2005) Enhanced therapeutic effect by combination of tumor-targeting Salmonella and endostatin in murine melanoma model. Cancer Biol Ther 4:840–845CrossRefPubMedGoogle Scholar
  11. 11.
    Tjuvajev J, Blasberg R, Luo X, Zheng LM, King I, Bermudes D (2001) Salmonella-based tumor-targeted cancer therapy: tumor amplified protein expression therapy (TAPET) for diagnostic imaging. J Control Release 74:313–315CrossRefPubMedGoogle Scholar
  12. 12.
    Yu YA, Shabahang S, Timiryasova TM et al (2004) Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 22:313–320CrossRefPubMedGoogle Scholar
  13. 13.
    Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Kishimoto H, Bouvet M, Hoffman RM (2009) Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium. Cell Cycle 8:870–875CrossRefPubMedGoogle Scholar
  14. 14.
    Zhang Y, Zhang N, Zhao M, Hoffman RM (2015) Comparison of the selective targeting efficacy of Salmonella typhimurium A1-R and VNP20009 on the Lewis lung carcinoma in nude mice. Oncotarget 6:14625–14631PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Jia LJ, Wei DP, Sun QM, Huang Y, Wu Q, Hua ZC (2007) Oral delivery of tumor-targeting Salmonella for cancer therapy in murine tumor models. Cancer Sci 98:1107–1112CrossRefPubMedGoogle Scholar
  16. 16.
    Chen G, Wei DP, Jia LJ, Tang B, Shu L, Zhang K, Xu Y, Gao J, Huang XF, Jiang WH, Hu QG, Huang Y, Wu Q, Sun ZH, Zhang JF, Hua ZC (2009) Oral delivery of tumor-targeting Salmonella exhibits promising therapeutic efficacy and low toxicity. Cancer Sci 100:2437–2443CrossRefPubMedGoogle Scholar
  17. 17.
    Zhang Y, Tome Y, Suetsugu A, Zhang L, Zhang N, Hoffman R, Zhao M (2012) Determination of the optimal route of administration of Salmonella typhimurium A1-R to target breast cancer in nude mice. Anticancer Res 32:2501–2508PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Cancer InstituteFudan University Shanghai Cancer CenterShanghaiChina
  2. 2.Department of Oncology, Nanjing First HospitalNanjing Medical UniversityNanjingChina

Personalised recommendations